These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 3432553

  • 1. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils.
    Spinnewyn B, Blavet N, Clostre F, Bazan N, Braquet P.
    Prostaglandins; 1987 Sep; 34(3):337-49. PubMed ID: 3432553
    [Abstract] [Full Text] [Related]

  • 2. The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat.
    Liu XH, Eun BL, Silverstein FS, Barks JD.
    Pediatr Res; 1996 Dec; 40(6):797-803. PubMed ID: 8947953
    [Abstract] [Full Text] [Related]

  • 3. Arachidonic acid metabolism and cerebral blood flow in the normal, ischemic, and reperfused gerbil brain. Inhibition of ischemia-reperfusion-induced cerebral injury by a platelet-activating factor antagonist (BN 52021).
    Panetta T, Marcheselli VL, Braquet P, Bazan NG.
    Ann N Y Acad Sci; 1989 Dec; 559():340-51. PubMed ID: 2774404
    [Abstract] [Full Text] [Related]

  • 4. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N, Etienne A, Braquet P.
    Agents Actions Suppl; 1986 Dec; 20():87-97. PubMed ID: 3028108
    [Abstract] [Full Text] [Related]

  • 5. Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo.
    Prehn JH, Krieglstein J.
    J Neurosci Res; 1993 Feb 01; 34(2):179-88. PubMed ID: 8095559
    [Abstract] [Full Text] [Related]

  • 6. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
    Nunez D, Chignard M, Korth R, Le Couedic JP, Norel X, Spinnewyn B, Braquet P, Benveniste J.
    Eur J Pharmacol; 1986 Apr 16; 123(2):197-205. PubMed ID: 3086108
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.
    Lamant V, Mauco G, Braquet P, Chap H, Douste-Blazy L.
    Biochem Pharmacol; 1987 Sep 01; 36(17):2749-52. PubMed ID: 2820421
    [Abstract] [Full Text] [Related]

  • 11. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity.
    Mandi Y, Farkas G, Koltai M, Beladi I, Mencia-Huerta JM, Braquet P.
    Immunology; 1989 Jul 01; 67(3):370-4. PubMed ID: 2759659
    [Abstract] [Full Text] [Related]

  • 12. The effect of a platelet activating factor antagonist (BN 52021) on neurologic outcome and histopathology in a canine model of complete cerebral ischemia.
    Hofer RE, Christopherson TJ, Scheithauer BW, Milde JH, Lanier WL.
    Anesthesiology; 1993 Aug 01; 79(2):347-53. PubMed ID: 8342844
    [Abstract] [Full Text] [Related]

  • 13. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
    Berti F, Omini C, Rossoni G, Braquet P.
    Pharmacol Res Commun; 1986 Sep 01; 18(9):775-93. PubMed ID: 3099317
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba.
    Touvay C, Etienne A, Braquet P.
    Agents Actions; 1986 Jan 01; 17(3-4):371-2. PubMed ID: 3754380
    [Abstract] [Full Text] [Related]

  • 15. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF).
    Smith PF, Maclennan K, Darlington CL.
    J Ethnopharmacol; 1996 Mar 01; 50(3):131-9. PubMed ID: 8691847
    [Abstract] [Full Text] [Related]

  • 16. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents.
    Braquet P, Hosford D.
    J Ethnopharmacol; 1991 Apr 01; 32(1-3):135-9. PubMed ID: 1881152
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021.
    Vilain B, Lagente V, Touvay C, Desquand S, Randon J, Lefort J, Braquet P, Vargaftig BB.
    Pharmacol Res Commun; 1986 Aug 01; 18 Suppl():119-26. PubMed ID: 3774840
    [Abstract] [Full Text] [Related]

  • 18. Thrombus induction by endogenic paf-acether and its inhibition by Ginkgo Biloba extracts in the guinea pig.
    Bourgain RH, Maes L, Andries R, Braquet P.
    Prostaglandins; 1986 Jul 01; 32(1):142-4. PubMed ID: 3763943
    [Abstract] [Full Text] [Related]

  • 19. The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021.
    Braquet P, Guinot P, Touvay C.
    Agents Actions Suppl; 1987 Jul 01; 21():97-117. PubMed ID: 3314418
    [No Abstract] [Full Text] [Related]

  • 20. Antagonism of platelet activating factor-induced chemiluminescence in guinea-pig peritoneal macrophages in differing states of activation.
    Parnham MJ, Bittner C, Lambrecht G.
    Br J Pharmacol; 1989 Oct 01; 98(2):574-80. PubMed ID: 2819335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.